Thibaut V.
- Country
- Belgium
- Department
- Department of Clinical Sciences
Research Overview
- Comparison of Weekly Versus Event-Driven Doxycycline Post-Exposure Prophylaxis for the Prevention of Sexually Transmitted Infections in MSM and TGW Receiving HIV-PrEP
- Efficacy of Doxycycline Monohydrate in Reducing Bacterial STIs in MSM and TGW with HIV: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial
Data & Insights
Has run more than one trial at 1 of 2 partner sites.
Specializations
HIV and Antiretroviral Therapy
Thibaut Vanbaelen’s clinical research includes treatment strategies for HIV infection, with attention to antiretroviral regimen selection, viral suppression, and care for people presenting with advanced or late-diagnosed disease. The work also extends to individuals living with ongoing viremia and treatment-experienced populations.
- Antiretroviral treatment optimization
- Advanced and late-presenting HIV disease
- Long-acting and oral HIV therapy
His activity at the Institute of Tropical Medicine in Antwerp places HIV therapeutics at the center of his clinical trial portfolio.
Sexually Transmitted Infections and Prevention
His research landscape strongly features prevention and management of sexually transmitted infections, including bacterial infections such as chlamydia, gonorrhea, and syphilis. This work also covers prevention approaches for people at elevated sexual health risk, particularly among MSM and TGW populations.
- Bacterial sexually transmitted diseases
- Doxycycline post-exposure prophylaxis
- Sexual health in people living with HIV
His trial activity reflects a therapeutic focus on infection prevention, sexual health protection, and reduction of recurrent bacterial transmission.
Vaccine Research and Immunization
Thibaut Vanbaelen is involved in clinical studies on vaccination and immunogenicity across several infectious diseases, including influenza, respiratory syncytial virus, yellow fever, rabies, and mpox. His interests include vaccine response in healthy volunteers and in adult populations requiring protection against viral infection.
- Influenza prevention
- RSV immunization
- Rabies and yellow fever vaccination
- Mpox prevention
The portfolio also includes combined vaccine evaluation and route-of-administration questions relevant to preventive immunology.
Herpes Simplex and Mpox Therapeutics
His clinical trial activity includes therapeutic and preventive research in herpes simplex virus infection and mpox, with attention to symptom control, recurrence reduction, and protection against viral disease. These studies align with a broader interest in emerging and recurrent viral infections affecting sexual health and community transmission.
- Recurrent genital herpes
- Mpox treatment and prevention
- Viral lesion resolution
This area of work connects antiviral innovation with clinically relevant outcomes in mucocutaneous viral disease.
Antimicrobial Resistance and Chemsex-Related Health
Another part of his research landscape addresses antimicrobial resistance, particularly in Escherichia coli, alongside clinical issues linked to chemsex-related drug use. This includes interest in how preventive antibiotic exposure may influence bacterial susceptibility and how craving-related health needs intersect with sexual health.
- Resistance in Escherichia coli
- Antibiotic susceptibility
- Chemsex-related drug craving
His trial involvement also touches on the therapeutic interface between infection prevention and behavioral health in high-risk adult populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.